SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference as Astex Pharmaceuticals, Inc. on September 12th
September 02 2011 - 6:00AM
Business Wire
SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated
to the discovery and development of novel cancer therapies, today
announced that James S.J. Manuso, Ph.D., chairman and chief
executive officer, and Harren Jhoti, Ph.D., president, will present
at the Rodman & Renshaw 13th Annual Healthcare Conference on
Monday, September 12th in New York as Astex Pharmaceuticals, Inc.,
subject to final legal and NASDAQ listing approvals.
The Company's presentation will begin at 11:40 a.m. ET. A live
webcast of the presentation will be available in the Investor
Events section of the Company's website. The webcast will be
archived for 30 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery
and development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. SuperGen developed Dacogen® and
receives significant royalties on global sales.
For more information about SuperGen, please visit
http://www.supergen.com.
Note on Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934,
including but not limited to, statements regarding the expectation
that the Company will change its name and ticker symbol. These and
other forward-looking statements involve certain risks and
uncertainties that could cause actual results to differ materially
from those indicated in such forward-looking statements, including,
but not limited to, the ability of the Company to change its name
and its ticker symbol, and such other risks as identified in the
Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2010, and the Company’s most recent Quarterly
Reports on Form 10-Q, each as filed with the SEC, which
contain and identify important factors that could cause the actual
results to differ materially from those contained in the
forward-looking statements. The Company assumes no obligation to
update any forward-looking statement contained in this press
release.
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Sep 2023 to Sep 2024